Attached files
file | filename |
---|---|
10-Q - ASTERIAS BIOTHERAPEUTICS, INC. 10-Q 9-30-2014 - Asterias Biotherapeutics, Inc. | form10q.htm |
EX-31 - EXHIBIT 31 - Asterias Biotherapeutics, Inc. | ex31.htm |
EX-3.2 - EXHIBIT 3.2 - Asterias Biotherapeutics, Inc. | ex3_2.htm |
EX-10.1 - EXHIBIT 10.1 - Asterias Biotherapeutics, Inc. | ex10_1.htm |
EXCEL - IDEA: XBRL DOCUMENT - Asterias Biotherapeutics, Inc. | Financial_Report.xls |
Exhibit 32
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Asterias Biotherapeutics, Inc. (the "Company") for the quarter ended September 30, 2014 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), each of the undersigned, Pedro Lichtinger and Robert W. Peabody, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: November 10, 2014
|
|
s/ Pedro Lichtinger
|
|
Pedro Lichtinger
|
|
Principal Executive Officer
|
s/ Robert W. Peabody
|
|
Robert W. Peabody
|
|
Principal Financial Officer
|